Murine genetic deficiency of neuronal nitric oxide synthase (nNOS-/-) and interstitial cells of Cajal (W/Wv): Implications for achalasia?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 10, 2014, Pages 1800-1807

  Müller, Michaela ^a   Colcuc, Sebastian ^b   Drescher, Daniel G ^b   Eckardt, Alexander J ^a   von Pein, Harald ^b   Taube, Christian ^b   Schumacher, Johannes ^c   Gockel, Henning R ^b   Schimanski, Carl C ^b   Lang, Hauke ^b   Gockel, Ines ^b  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Achalasia; Interstitial cells of Cajal; Lower esophageal sphincter; Nitric oxide; Vasoactive intestinal peptide

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL; DEFICIENCY; ESOPHAGEAL ACHALASIA; FEMALE; GENE DELETION; GENETICS; HUMAN; INBRED MOUSE STRAIN; INTERSTITIAL CELL OF CAJAL; LOWER ESOPHAGUS SPHINCTER; MALE; MANOMETRY; PATHOPHYSIOLOGY; PERISTALSIS; PHYSIOLOGY;

ANIMALS; ESOPHAGEAL ACHALASIA; ESOPHAGEAL SPHINCTER, LOWER; FEMALE; GENE DELETION; HUMANS; INTERSTITIAL CELLS OF CAJAL; MALE; MANOMETRY; MICE, INBRED STRAINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; PERISTALSIS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84911974715     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12600     Document Type: Article

References (37)

1. Goyal RK, Chaudhury A. Physiology of normal esophageal motility. J. Clin. Gastroenterol. 2008; 42: 610-619.
2. Van Geldre LA, Lefebvre RA. Interaction of NO and VIP in gastrointestinal smooth muscle relaxation. Curr. Pharm. Des. 2004; 10: 2483-2497.
3. Daniel EE, Helmy-Elkholy A, Jager LP, Kannan MS. Neither a purine nor VIP is the mediator of inhibitory nerves of opossum esophageal smooth muscle. J. Physiol. 1983; 336: 243-260.
4. Farre R, Sifrim D. Regulation of basal tone, relaxation and contraction of the lower oesophageal sphincter. Relevance to drug discovery for oesophageal disorders. Br. J. Pharmacol. 2008; 153: 858-869.
5. Ward SM, Morris G, Reese L, Wang XY, Sanders KM. Interstitial cells of Cajal mediate enteric inhibitory neurotransmission in the lower esophageal and pyloric sphincters. Gastroenterology 1998; 115: 314-329.
6. Akaki MT. Gut pacemaker cells: the interstitial cells of Cajal (ICC). Mini review. J. Smooth Muscle Res. 2003; 39: 137-161.
7. Gockel I, Bohl JR, Eckardt VF, Junginger T. Reduction of interstitial cells of Cajal (ICC) associated with neuronal nitric oxide synthase (n-NOS) in patients with achalasia. Am. J. Gastroenterol. 2008; 103: 856-864.
8. v mutant mice. Gastroenterology 2001; 121: 34-42.
9. Sanders KM, Ward SM, Daniel EE. ICC in neurotransmission: hard to swallow a lack of involvement. Gastroenterology 2002; 122: 1185-1186; author reply 1186-7.
10. Diamant NE. Physiology of esophageal motor function. Gastroenterol. Clin. North Am. 1989; 18: 179-194.
11. De Giorgio R, Di Simone MP, Stanghellini V etal. Esophageal and gastric nitric oxide synthesizing innervations in primary achalasia. Am. J. Gastroenterol. 1999; 94: 2357-2362.
12. Boeckxstaens GE. The lower esophageal sphincter. Neurogastroenterol. Motil. 2005; 17: 13-21.
13. Eliasson MJ, Blackshaw S, Schell MJ, Snyder SH. Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. Proc. Natl Acad. Sci. U.S.A. 1997; 94: 3396-3401.
14. Richter JE, Blackwell JN, Wu WC, Johns DN, Cowan RJ, Castell DO. Relationship of radionuclide liquid bolus transport and esophageal manometry. J. Lab. Clin. Med. 1987; 109: 217-224.
15. Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am. J. Gastroenterol. 2005; 100: 1404-1414.
16. Takahashi T. Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J. Gastroenterol. 2003; 38: 421-430.
17. Mostafa RM, Moustafa YM, Hamdy H. Interstitial cells of Cajal, the Maestro in health and disease. World J. Gastroenterol. 2010; 16: 3239-3248.
18. Mearin F, Mourelle M, Guarner F etal. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur. J. Clin. Invest. 1993; 23: 724-728.
19. Kim CD, Goyal RK, Mashimo H. Neuronal NOS provides nitrergic inhibitory neurotransmitter in mouse lower esophageal sphincter. Am. J. Physiol. 1999; 277: 280-284.
20. Khelif K, De Laet MH, Chaouachi B, Segers V, Vanderwinden JM. Achalasia of the cardia in Allgrove's (triple A) syndrome: histopathologic study of 10 cases. Am. J. Surg. Pathol. 2003; 27: 667-672.
21. Sanders KM. A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology 1996; 111: 492-515.
22. Iino S, Horiguchi K. Interstitial cells of cajal are involved in neurotransmission in the gastrointestinal tract. Acta Histochem. Cytochem. 2006; 39: 145-153.
23. Ward SM, Sanders KM. Interstitial cells of Cajal: primary targets of enteric motor innervation. Anat. Rec. 2001; 262: 125-135.
24. Ward SM, McLaren GJ, Sanders KM. Interstitial cells of Cajal in the deep muscular plexus mediate enteric motor neurotransmission in the mouse small intestine. J. Physiol. 2006; 573: 147-159.
25. Negreanu LM, Assor P, Mateescu B, Cirstoiu C. Interstitial cells of Cajal in the gut-a gastroenterologist's point of view. World J. Gastroenterol. 2008; 14: 6285-6288.
26. Villanacci V, Annese V, Cuttitta A etal. An immunohistochemical study of the myenteric plexus in idiopathic achalasia. J. Clin. Gastroenterol. 2010; 44: 407-410.
27. Vanderwinden JM, Rumessen JJ. Interstitial cells of Cajal in human gut and gastrointestinal disease. Microsc. Res. Tech. 1999; 47: 344-360.
28. Dickens EJ, Edwards FR, Hirst GD. Selective knockout of intramuscular interstitial cells reveals their role in the generation of slow waves in mouse stomach. J. Physiol. 2001; 531: 827-833.
29. Park H, Conklin JL. Neuromuscular control of esophageal peristalsis. Curr. Gastroenterol. Rep. 1999; 1: 186-197.
30. Wörl J, Dütsch F, Neuhuber WL. Development of neuromuscular junctions in the mouse esophagus: focus on establishment and reduction of enteric co-innervation. Anat. Embryol. (Berl) 2002; 205: 141-152.
31. Voice JL, Dorsam G, Chan RC, Grinninger C, Kong Y, Goetzl EJ. Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide. Regul. Pept. 2002; 109: 199-208.
32. Pozo D, Delgado M. The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide? FASEB J. 2004; 18: 1325-1334.
33. Paladini F, Cocco E, Cascino I etal. Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene. Neurogastroenterol. Motil. 2009; 21: 597-602.
34. Naftali T, Levit T, Pomeranz I, Benjaminov FS, Konikoff FM. Nonspecific esophageal motility disorders may be an early stage of a specific disorder, particularly achalasia. Dis. Esophagus 2009; 22: 611-615.
35. Ghoshal UC, Daschakraborty SB, Singh R. Pathogenesis of achalasia cardia. World J. Gastroenterol. 2012; 18: 3050-3057.
36. Coccia G, Bortolotti M, Michetti P, Dodero M. Prospective clinical and manometric study comparing pneumatic dilatation and sublingual nifedipine in the treatment of oesophageal achalasia. Gut 1991; 32: 604-606.
37. Mazzanti B, Lorenzi B, Lorenzoni P etal. Treatment of experimental esophagogastric myotomy with bone marrow mesenchymal stem cells in a rat model. Neurogastroenterol. Motil. 2013; 25: e669-679.